The impact of chronic kidney disease on mortality, quality of life and cost of medical care is rising worldwide, such that it now affects 8-16% of the world population.
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In Brazil, data from the National Dialysis Registry and the Ministry of Health have shown that over 10,000 people are currently undergoing kidney replacement therapy. 4 de Moura et al. analyzed data from the Brazilian National Health System on 280,667 patients with end-stage renal disease who received publicly financed kidney replacement therapy for at least three consecutive months. Men (57.2%) and people aged 45-64 years (43.4%) were predominant. The underlying causes of CKD were hypertension (20.4%), diabetes (12.0%) and glomerulonephritis (7.7%). The annual increase in the prevalence of people under dialysis from 2000 to 2012 was 3.6% (95% confidence interval, CI: +3.2% to +4.0%) and the average annual change in incidence was +1.8%/year (+1.1% to +2.5%). 5 The prevalence of CKD among apparently healthy people was analyzed among the participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). 6, 7 This was eval- was derived from pooled data from clinical studies in the United States. 8 In ELSA-Brasil, the frequency of albuminuria or low glomerular filtration rate, alone or in combination, was related to aging, lower socioeconomic status and self-reporting as black. Risk factors such as smoking, dyslipidemia, hypertension and diabetes were directly correlated with CKD. However, these risk factors did not explain the socioeconomic differences, i.e. the higher prevalence of CKD among the elderly, less affluent people and blacks. 9 One point to emphasize is that ELSA-Brasil researchers did not correct the glomerular filtration rate for race in the manner proposed by the CKD-EPI consortium. 8 The reason for their race correction was the greater mass muscle described in the African-American population.
However, in contrast with research conducted in the United States, three independent studies in different Brazilian cities did not show that correction for black race was useful for the Brazilian population. [10] [11] [12] These conclusions were the same as those relating to black people living in Ghana and South Africa. 13, 14 In the light of these results in Brazil and Africa, there is no reason for medical laboratories in Brazil to keep on presenting glomerular filtration rates corrected for race.
Although the U.S. Preventive Services Task Force concluded that the "evidence is insufficient to assess the balance of benefits and harms of routine screening for CKD in asymptomatic adults, " 15 we consider that creatinine measurements should be more widely used, so that glomerular filtration rates are not just estimated for people with hypertension or diabetes. As shown by the ELSA-Brasil results, socioeconomic status was inversely associated with CKD prevalence. Consequently, screening for CKD within primary care, especially at units located in places with poor and less educated populations, needs to evaluate this better: not only from a cost-effectiveness perspective but also from the perspective of the necessity to reduce inequity within the Brazilian population.
